Nov. 6, 2025

Legislation is moving forward in the Pennsylvania House of Representatives (House Bill 1123) that would amend the state’s Insurance Company Law to mandate health insurance plans cover colorectal cancer screening tests without cost sharing beginning at age 45 instead of 50. Under the proposed measure, health insurers would have to provide coverage for nonsymptomatic individuals for: annual fecal immunochemical test; CT colonography at least every five years; and a multi-target stool DNA test every one to three years. Coverage for these tests must be provided without cost sharing — with no deductible, coinsurance or copayment.

If enacted, the measure would also mandate full coverage for follow-up colonoscopies after a positive noninvasive stool-based or visualization test result. “Colorectal cancer screening tests” are defined in the draft measure to include fecal occult or immunochemical tests, flexible sigmoidoscopy, colonoscopy, screening barium enema, CT colonography, multi-target stool DNA tests, or other tests consistent with approved medical standards.

For more information, contact Eugenia Brandt, ACR® Senior Government Relations Director, or Dillon Harp, Senior State Government Relations Specialist.

To see all legislation tracked by ACR visit the College’s interactive policy map.

Related ACR News

  • CMS Releases 2026 Medicare Physician Fee Schedule Final Rule

    CMS released the 2026 MPFS final rule Oct. 31. ACR prepared an initial summary about impact on imaging.

    Read more
  • Massachusetts Legislature Updates Prior Authorization Bill

    Massachusetts HB 4616 aims to streamline prior authorization, boost transparency, and study its impact on care access and costs.

    Read more
  • ACR Responds to RFI on AI Regulatory Reform

    ACR urged the White House to enhance AI oversight and payment policies to support safe, effective, and reimbursable clinical AI use.

    Read more